FATE
Fate Therapeutics·NASDAQ
--
--(--)
--
--(--)
1.99 / 10
Underperform
Technical analysis yields 1.99/10, manifesting challenging technical structure. Affirmative signals in no significant factors conflict with discouraging patterns in MACD Death Cross, Dark Cloud Cover, and Long Lower Shadow. Technical assessment: cautious.
Analysis Checks(0/3)
Long Lower Shadow
Score2.65/10
Win Rate43.40%
Hist. Signals53
Avg Return1.28%
Score2.65/10
Win Rate43.40%
Hist. Signals53
Avg Return1.28%
Dark Cloud Cover
Score2.32/10
Win Rate46.15%
Hist. Signals13
Avg Return-1.35%
Score2.32/10
Win Rate46.15%
Hist. Signals13
Avg Return-1.35%
MACD Death Cross
Score1/10
Win Rate20.00%
Hist. Signals10
Avg Return-1.43%
Score1/10
Win Rate20.00%
Hist. Signals10
Avg Return-1.43%
Long Lower Shadow
Score2.65/10
Win Rate43.40%
Hist. Signals53
Avg Return1.28%
Score2.65/10
Win Rate43.40%
Hist. Signals53
Avg Return1.28%
MACD Death Cross
Score1/10
Win Rate20.00%
Hist. Signals10
Avg Return-1.43%
Score1/10
Win Rate20.00%
Hist. Signals10
Avg Return-1.43%
Dark Cloud Cover
Score2.32/10
Win Rate46.15%
Hist. Signals13
Avg Return-1.35%
Score2.32/10
Win Rate46.15%
Hist. Signals13
Avg Return-1.35%
Technical Analysis of FATE?
- FATE presents a Underperform setup with a Technical Score of 1.99/10. Key technical indicators highlight an RSI of 50.25 and a MACD of -0.02, with the trend anchored by the 50-Day SMA at 1.09. Traders should monitor key support at 1.01 and resistance at 1.11.
